PPIF and metabolic dysfunction-associated steatohepatitis: While CypD KO mice developed multiple features of NAFLD/NASH, they were significantly protected from the development of HCC, both in terms of tumor size and number and overall resembled mice in an earlier stage of the disease compared to wild-type mice.